Search research articles
Contact Us
Filters
Showing results (51-60 of 249) with videos related to
Page
of 25
Sort By:
Nederlands Tijdschrift Voor Geneeskunde
|
July 15, 1989
[Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes]
A M Eggermont, G Stoter, R L Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 4, 1987
[Severe tissue necrosis due to extravasation of mitomycin]
T H Bikkers, J Verweij, A N van Geel, et al.
European Journal of Nuclear Medicine
|
January 1, 1988
Indium 111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma
P H Cox, J Verweij, M Pillay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer
M H Silbermann, B vd Vecht, G Stoter, et al.
Cytometry
|
March 1, 1997
Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry
A W Boersma, K Nooter, H Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens
H Burger, M A den Bakker, G Stoter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2003
Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma
L Kloos, P Sillevis Smitt, C W Ang, et al.
British Journal of Cancer
|
March 1, 1990
Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
C J Punt, S C Henzen-Logmans, R L Bolhuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
J Verweij, D Gandia, A S Planting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1990
Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group
C Sessa, W ten Bokkel Huinink, G Stoter, et al.
Page
of 25
Search research articles
Search
Showing results (51-60 of 249) with videos related to
Sort By:
Page
of 25
Nederlands Tijdschrift Voor Geneeskunde
|
July 15, 1989
[Adoptive immunotherapy with interleukin-2 and with interleukin-2 activated lymphocytes]
A M Eggermont, G Stoter, R L Jansen, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
April 4, 1987
[Severe tissue necrosis due to extravasation of mitomycin]
T H Bikkers, J Verweij, A N van Geel, et al.
European Journal of Nuclear Medicine
|
January 1, 1988
Indium 111 antimyosin for the detection of leiomyosarcoma and rhabdomyosarcoma
P H Cox, J Verweij, M Pillay, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 1, 1990
Combination therapy of ACNU and ifosfamide in tumor bearing mice with M2661 breast cancer, B16 malignant melanoma or C38 colon cancer
M H Silbermann, B vd Vecht, G Stoter, et al.
Cytometry
|
March 1, 1997
Bax upregulation is an early event in cisplatin-induced apoptosis in human testicular germ-cell tumor cell line NT2, as quantitated by flow cytometry
A W Boersma, K Nooter, H Burger, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 26, 2003
Lack of c-kit exon 11 activating mutations in c-KIT/CD117-positive SCLC tumour specimens
H Burger, M A den Bakker, G Stoter, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
March 18, 2003
Paraneoplastic ophthalmoplegia and subacute motor axonal neuropathy associated with anti-GQ1b antibodies in a patient with malignant melanoma
L Kloos, P Sillevis Smitt, C W Ang, et al.
British Journal of Cancer
|
March 1, 1990
Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
C J Punt, S C Henzen-Logmans, R L Bolhuis, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1993
Phase II study of oral miltefosine in patients with squamous cell head and neck cancer
J Verweij, D Gandia, A S Planting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1990
Phase II study of 5-aza-2'-deoxycytidine in advanced ovarian carcinoma. The EORTC Early Clinical Trials Group
C Sessa, W ten Bokkel Huinink, G Stoter, et al.
Page
of 25